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The prevalence of childhood overweight and obesity is increasing in the last decades, also in children with Cerebral Palsy (CP). Even
though it has been established that an increase in weight can have important negative effects on gait in healthy adults and
children, it has not been investigated what the effect is of an increase in body weight on the characteristics of gait in children
with CP. In CP, pre and post three-dimensional gait analyses are performed to assess the effectiveness of an intervention. As a
considerable amount of time can elapse between these measurements, and the effect of an alteration in the body weight is not
taken into consideration, this effect of increased body weight is of specific importance.
Thirty children with the predominantly spastic type of CP and fifteen typically developing (TD) children were enrolled (age 3 to 15
years). All children underwent three-dimensional gait analysis with weight-free (baseline) and weighted (10% of the body weight
added around their waist) trials.
Numerous gait parameters showed a different response to the added weight for TD and CP children. TD children increased walking
velocity, step- and stride length, and decreased double support duration with a slightly earlier timing of foot-off, while the
opposite was found in CP. Similarly, increased ranges of motion at the pelvis (coronal plane) and hip (all planes), higher joint angular
velocities at the hip and ankle, as well as increased moments and powers at the hip, knee and ankle were observed for TD
children, while CP children did not change or even showed decreases in the respective measures in response to walking with
added weight. Further, while TD children increased their gastrocnemius EMG amplitude during weighted walking, CP children
slightly decreased their gastrocnemius EMG amplitude.
As such, an increase in weight has a significant effect on the gait pattern in CP children. Clinical gait analysists should therefore
take into account the negative effects of increased weight during pre-post measurements to avoid misinterpretation of treatment
results. Overweight and obesity in CP should be counteracted or prevented as the increased weight has detrimental effects on the
gait pattern.
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Abstract 66 
The prevalence of childhood overweight and obesity is increasing in the last decades, also in 67 
children with Cerebral Palsy (CP). Even though it has been established that an increase in 68 
weight can have important negative effects on gait in healthy adults and children, it has not 69 
been investigated what the effect is of an increase in body weight on the characteristics of gait 70 
in children with CP. In CP, pre and post three-dimensional gait analyses are performed to assess 71 
the effectiveness of an intervention. As a considerable amount of time can elapse between these 72 
measurements, and the effect of an alteration in the body weight is not taken into consideration, 73 
this effect of increased body weight is of specific importance. 74 
Thirty children with the predominantly spastic type of CP and fifteen typically developing (TD) 75 
children were enrolled (age 3 to 15 years). All children underwent three-dimensional gait 76 
analysis with weight-free (baseline) and weighted (10% of the body weight added around their 77 
waist) trials. 78 
Numerous gait parameters showed a different response to the added weight for TD and CP 79 
children. TD children increased walking velocity, step- and stride length, and decreased double 80 
support duration with a slightly earlier timing of foot-off, while the opposite was found in CP. 81 
Similarly, increased ranges of motion at the pelvis (coronal plane) and hip (all planes), higher 82 
joint angular velocities at the hip and ankle, as well as increased moments and powers at the 83 
hip, knee and ankle were observed for TD children, while CP children did not change or even 84 
showed decreases in the respective measures in response to walking with added weight. Further, 85 
while TD children increased their gastrocnemius EMG amplitude during weighted walking, CP 86 
children slightly decreased their gastrocnemius EMG amplitude.  87 
As such, an increase in weight has a significant effect on the gait pattern in CP children. Clinical 88 
gait analysists should therefore take into account the negative effects of increased weight during 89 
pre-post measurements to avoid misinterpretation of treatment results. Overweight and obesity 90 
in CP should be counteracted or prevented as the increased weight has detrimental effects on 91 
the gait pattern.  92 
 93 
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1. Introduction 97 
According to the World Health Organization (WHO), in 2014 more than 1.9 billion adults 98 
were overweight. Of these over 600 million were obese (World Health Organization, 2016b). 99 
Furthermore, the worldwide prevalence of obesity has more than doubled between 1980 and 100 
2013 (Finucane et al., 2011; Ng et al., 2014). 101 
Obesity has an important impact on reduced quality of life (Taylor et al., 2013) and public 102 
health (Visscher and Seidell, 2001), as it is related to the development of several non-103 
communicable diseases such as cardiovascular disease, type 2 diabetes mellitus, and 104 
osteoarthritis (World Health Organization, 2016b). 105 
Similarly, in children an increase in overweight and obesity has been observed over the last 106 
decades (de Onis et al., 2010). This is not only the case in typically developing children 107 
(TDc), but also in children that already present with a pathology; e.g. children with Cerebral 108 
Palsy (CPc) (Park et al., 2011; Rogozinski et al., 2007). 109 
Cerebral Palsy is the most common developmental cause of physical disability in the world 110 
(Aisen et al., 2011), with a prevalence of 2-3 in 1000 live births (Odding et al., 2006). It 111 
originates from non-progressive impairments to the brain before, during or shortly after birth 112 
(Bax et al., 2005), resulting in persistent (primary) motor and sensory impairments such as 113 
abnormal motor control, muscle strength, and/or muscle tone. As a result of abnormal muscle 114 
activity or loading of the bones, secondary impairments can develop over time, such as 115 
shortened muscles which will restrict the joint range of motion. These primary and secondary 116 
impairments result in a pathological gait pattern in CPc. 117 
Many treatment modalities in CP are aimed at improving the gait pattern, by focusing on the 118 
primary and secondary impairments. Orthoses, for instance, are often used to control the 119 
position and movement of the ankle (Novacheck et al., 2009). Neurosurgery, on the other 120 
hand, can reduce the patient’s spasticity by means of selective dorsal rhizotomy or intrathecal 121 
baclofen, while orthopedic surgery can address bone deformities and muscle contractures 122 
(Novacheck and Gage, 2007). Gait analysis has a crucial role in the treatment of gait 123 
impairments in CPc, as it allows 1) the identification of the specific deficits of each patient, 124 
and 2) the evaluation of the outcome of treatment interventions specifically selected to target 125 
those deficits (Novacheck and Gage, 2007; Schwartz et al., 2004). 126 
Interventions in CPc are often assessed via pre-post treatment three-dimensional gait analysis. 127 
Until now though, the effect of an alteration in the body weight is usually not taken into 128 
consideration when interpreting pre-post data, even though a considerable amount of time can 129 
elapse between the two measurements. 130 
However, literature in other populations provides indications that changes in body weight 131 
result in alterations in the gait pattern. In children with overweight and obesity for example, it 132 
has been reported that additional body mass leads to higher foot loading, with a 133 
disproportional impact on the midfoot area (Cousins et al., 2013; Mueller et al., 2016). Both 134 
adults and children with obesity have been found to walk with increased peak knee adduction 135 
moments (which may result in excessive joint loading) (Browning and Kram, 2007; Gushue et 136 
al., 2005). Adults with obesity also have been reported to walk with increased external knee 137 
flexion moments, and decreased knee rotation moments compared to non-overweight adults 138 
(Harding et al., 2012). 139 
Furthermore, some researchers have indicated changes in EMG activations due to obesity in 140 
children and adults as well. Blakemore et al. (2013), showed that during fast walking, 141 
overweight children had longer gastrocnemius activity during stance, but shorter 142 
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gastrocnemius activity during swing (Blakemore et al., 2013). A study by Amiri et al. (2015) 143 
indicated that adults with obesity walked with significantly prolonged gastrocnemius and 144 
quadriceps EMG activity during the stance phase (Amiri et al., 2015). In adults, walking 145 
while carrying load resulted in increased EMG activations of the vastus lateralis and 146 
gastrocnemius, as well as increased durations of biceps femoris, gastrocnemius, vastus 147 
lateralis and semimembranosus activity (Ghori and Luckwill, 1985; Simpson et al., 2011).  148 
As such it appears that increased weight has a significant effect on several aspects of the gait 149 
pattern, including kinematics, kinetics and EMG. 150 
To the best of our knowledge, the effect of increasing the body weight on the characteristics 151 
of gait in CPc has not yet been investigated. To examine this experimentally, one could either 152 
gradually increase the weight of CPc over several weeks, or investigate the effect of an 153 
immediate increase in weight. One could argue that the gait adaptations to an immediate 154 
increase of weight will not necessarily resemble those that happen during the slow increase in 155 
body weight as is the case for obesity. In the latter case, the gait pattern can slowly adapt to 156 
very small increments in weight. However, body weight can increase more rapidly during 157 
daily life as well i.e. during the growth spurt. During the grow spurt, ambulatory CPc 158 
typically show fast increases in body weight, similarly as TDc (Day et al., 2007). In the 159 
current study we have opted for the latter, as this is the first step to take to provide further 160 
insights into the possible adaptations in CPc to added weight. Thus, the experimental 161 
paradigm used in the current study, more closely resembles this phenomenon rather than a 162 
slow increase in body weight. As CPc often undergo treatment interventions at an age before 163 
or close to the growth spurt, it is of interest to investigate the influence of an immediate 164 
increase in weight on the gait parameters in CPc. 165 
 166 
The current study examined whether experimentally increasing the body weight influences the 167 
spatio-temporal gait characteristics, three-dimensional gait kinematics, kinetics, and EMG 168 
activations in CPc. We hypothesize that CPc will experience difficulties in adjusting their gait 169 
pattern to the added weights; i.e. they will present with more negative changes in their gait 170 
due to the increase of body weight compared to TDc (e.g. decrease walking speed, smaller 171 
step lengths and ranges of joint motion). Additionally, we hypothesize that more negative 172 
changes in the gait pattern will appear in CPc with relatively weaker lower limb muscles 173 
compared to children with relatively strong lower limb muscles as they will experience more 174 
difficulties negotiating the increased load imposed on their musculoskeletal system. 175 
 176 
  177 
In revi
w
6 
 
2. Materials and Methods 178 
2.1 Patients  179 
For this study, a group of CPc meeting specific inclusion criteria (CP group) was compared to 180 
a control group of TDc. The characteristics of both groups are discussed below and summarized 181 
in Table 1. A schematic overview of the study design can be found in Figure 1. 182 
Table 1 near here 183 
For the CP group, CPc were recruited at the Laboratory of Clinical Motion Analysis of the 184 
University Hospital Leuven (UZ Pellenberg), when they met the following inclusion criteria: 185 
(a) predominantly spastic type of CP, (b) age between 3 and 15 years, (c) ability to walk (with 186 
or without walking aids), (d) sufficient cooperation to follow verbal instructions, (e) no history 187 
of lower limb surgery, (f) no lower limb Botulinum Toxin-A treatment within 6 months prior 188 
to the 3DGA, and (g) adequate or moderate lower limb muscle strength. The latter was defined 189 
as a MMT-score of at least >2.5 on a 9-point scale (Table A, Supplementary Data) based on the 190 
MMT scale developed by Daniels & Worthingham’s scale for manual muscle testing (Cuthbert 191 
and Goodheart, 2007; Daniels and Worthingham, 1986). Strength was assessed for the knee 192 
flexors, knee extensors, and plantarflexors, as these muscles are assumed to be the main 193 
actuators for handling the additional load during the weighted walking (weighted walking task 194 
is described below). Based on the median MMT-score for these three muscle groups, the CPc 195 
were subdivided into two muscle strength groups: children whose median MMT ≥ 4 were 196 
classified into the adequate lower limb muscle strength group, while children with a median 197 
MMT-score between 2.5 and 4 were classified into the moderate lower limb muscle strength 198 
group. This cut-off value was selected based on the results of initial pilot tests where it was 199 
observed that children with a MMT score > 2.5 were still able to accurately execute the 200 
weighted walking task for the full testing procedure. In addition to strength, the selectivity of 201 
the three lower limb muscles was assessed using a five-point scale as described by Trost (Trost, 202 
2009) (Table A, Supplementary Data). 203 
Figure 1 near here 204 
Thirty CPc were enrolled in the CP group. Their average age was 8y 5m (±2y 3m). Twelve 205 
children were classified as unilaterally involved while 18 were bilaterally involved. Seventeen 206 
children were classified as GMFCS level I and 13 as level II. Seventeen children had adequate 207 
lower limb muscle strength, while 13 showed moderate lower limb muscle strength. Specific 208 
lower limb ranges of motion and levels of selective motor control are summarized in Table 1. 209 
The TD control group consisted of 15 children with an average age of 8y 6m (±1y 3m) without 210 
a history of orthopedic or neurological pathology. Comparison of the gait adaptations in 211 
response to the weighted walking task in the CP group to those observed in the TD group 212 
enabled the identification of ‘non-typical responses’ (gait adaptations that were not observed in 213 
the TD group). Non-typical responses unmask 3D gait parameters that alter due to the addition 214 
of weight which are specific to the CP group. 215 
To avoid the inclusion of correlated data we studied one of the lower limbs in each participant. 216 
Therefore, in CPc with unilateral involvement only the involved lower limb side was 217 
considered, while in children with bilateral involvement the most involved side was selected. 218 
When both sides were equally involved, the left or right lower limb was randomly selected. For 219 
TDc, only the right lower limb was investigated. 220 
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All experiments were approved by the local ethical committee and informed, written consent 221 
was obtained from the study subjects’ parents. 222 
 223 
2.2 3D gait analysis and weighted walking task 224 
Gait was evaluated through 3D gait analysis (3DGA). Prior to the 3DGA, lower limb 225 
dimensions, body height, and weight were measured to enable an estimation of joint center 226 
locations and segmental inertia parameters. Patients walked on a 10-meter walkway at a self-227 
selected speed. Spatiotemporal and kinematic measurements were collected using an eight-228 
camera VICON system (612 data capturing system measuring at 100Hz; VICON, Oxford 229 
Metrics, Oxford, UK), with the lower limb Plug-In-Gait marker set (Kadaba et al., 1990). Two 230 
force plates (Advanced Mechanical Technology Inc., Watertown, MA) were embedded in the 231 
walkway for force registration enabling calculation of kinetics. Surface EMG data were 232 
collected from the medial hamstrings, rectus femoris, and lateral gastrocnemius muscles using 233 
a 16 channel EMG system (K-lab, Biometrics, The Netherlands; or Zerowire, Aurion, Italy), 234 
synchronized with the motion capture system. EMG data was collected with a sampling rate of 235 
1500 Hz and filtered with a zero-phase 6th order butterworth filter with a passband ranging 236 
from 20 to 500Hz. Nexus software (Oxford Metrics, Oxford, UK) was used to define the gait 237 
cycles, to calculate the spatiotemporal parameters, and to estimate the joint angles and internal 238 
moments and powers normalized to body mass. Seventy-one discrete parameters were extracted 239 
from the continuous kinematic and kinetic waveforms based on a study of the literature 240 
(Goldberg et al., 2006; Inman et al., 1981; Perry, 1992; Schutte et al., 2000; Winter, 1987; Wolf 241 
et al., 2006) and the routine gait analysis protocol used for children with CP at the Clinical 242 
Movement Analysis Laboratory of the University Hospital Leuven (Pellenberg). 243 
All children walked barefoot (baseline/weight-free walking). In addition, all children executed 244 
the weighted walking task consisting of barefoot walking with 10% of the body weight added 245 
around the waist. This percentage of body weight was selected based on initial pilot tests (n=9). 246 
In these tests, it was observed that adding 10% of the body weight resulted in an increased load 247 
on the lower limbs without overloading, assuring the ability to walk across the gait lab for the 248 
full test procedure. The results from these pilot tests indicated that adding more than 10% of 249 
the body weight limited some patients to perform the walking trails. Hence, 10% of the body 250 
weight was chosen. The weight was applied evenly around the waist by means of a belt. The 251 
belt was positioned close to the level of S2 (approximate location of the centre of gravity) to 252 
avoid challenging the equilibrium of the children, and above the marker of the pelvis to ensure 253 
full visibility of the lower limb Plug-In-Gait marker set. For both conditions, the children 254 
walked at a self-selected speed until three trials with full kinematics, kinetics and EMG were 255 
recorded. Internal moments and powers for the weighted walking trials were normalized to the 256 
child’s body weight plus the additional weight.  257 
 258 
2.3 Statistical analysis 259 
For this study, a subset of 71 gait parameters was selected from the output of the 3DGA for 260 
both walking conditions (baseline and weighted walking). Spatiotemporal parameters, discrete 261 
values of joint angles, moments and powers at specific points in the gait cycle, and the mean 262 
EMG frequency over one full gait cycle were automatically extracted from the gait waveforms 263 
by means of custom-made software implemented in MATLAB (Mathworks). All parameters 264 
were averaged per walking condition over the three registered walking trials. Additionally, the 265 
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percentage increase/decrease in mean EMG amplitude (raw signal) in response to the added 266 
weight was calculated. All EMG parameters were investigated for the medial hamstrings, rectus 267 
femoris, and lateral gastrocnemius muscles. 268 
The difference scores between baseline walking and weighted walking were calculated for all 269 
the 3DGA parameters of the CP group and the TD group. These scores illustrate how the 270 
children responded to an increase in body weight. A Kruskal-Wallis test with post-hoc Mann-271 
Whitney U tests (with False Discovery Rate (FDR) correction for multiple testing) compared 272 
the responses of the TD children to the responses of (1) all CPc in the CP group, (2) CPc with 273 
adequate strength, and (3) CPc with moderate strength. A non-parametric method was applied 274 
as not all outcome parameters were characterized by a normal or Gaussian distribution. All 275 
statistical procedures were performed with the SAS system (SAS Institute Inc, SAS Campus, 276 
Dr. Cary, NC 27513). Level of significance was set at P < 0.05.  277 
 278 
  279 
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3. Results 280 
When children walked with added weight, changes in the gait pattern were observed for both 281 
TDc and CPc. However, for several 3DGA parameters, CPc responded significantly different 282 
to the added weight when compared to TDc. Tables 2 and 3 provide detailed results. 283 
Overall, the TDc appeared to increase their walking velocity, step- and stride length, and 284 
decreased their duration of double support while the timing of foot-off decreased slightly, while 285 
the opposite pattern was found in CPc (Figure 2 & Table 2). 286 
 Figure 2 near here 287 
Increased ranges of motion at the pelvis (coronal plane) and hip (all planes), as well as higher 288 
joint angular velocities at the hip and ankle appeared for TDc, while CPc did not seem to change 289 
or even decreased the respective ranges of motion and joint angular velocities in response to 290 
walking with added weight (Figure 2). Furthermore, several moments and powers at the hip, 291 
knee and ankle appeared to increase in TDc, while CPc mainly seemed to decrease their 292 
moments and powers during weighted walking (Table 2 & Table 3). 293 
 Table 2 near here 294 
 Table 3 near here 295 
Finally, a significantly different response in EMG amplitude could be observed in the 296 
gastrocnemius. In general, TDc increased their gastrocnemius EMG amplitude when they 297 
walked with added weight, while CPc slightly decreased their gastrocnemius EMG amplitude 298 
(Figure 3). 299 
 Figure 3 near here 300 
When the TD group was compared to the subgroups representing the adequately and moderately 301 
strong CP children separately, the response of four 3DGA parameters (timing of foot-off, pelvic 302 
range of motion in the coronal plane, maximal hip flexion in swing and maximal hip extension 303 
moment in stance) was found to differ significantly confirming the above described results 304 
(Tables 2 and 3). No differences in gait parameters due to the increased weight were found 305 
between the two CP groups (the adequately and moderately strong CPc). 306 
  307 
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4. Discussion 308 
Walking with extra weight applied around the waist resulted in multiple changes in the gait 309 
pattern of both TDc and CPc. For several 3DGA parameters, these changes were significantly 310 
different between the TDc and the CP group. 311 
The current results are of clinical importance as, due to the increase in prevalence of 312 
overweight and obesity in CPc over the last decades (Park et al., 2011; Rogozinski et al., 313 
2007), the gait pattern in CPc to date can be negatively influenced. Consequently, when 314 
interpreting 3D gait analysis data, weight should also be considered as a potential factor 315 
influencing the gait parameters. 316 
While TDc seemed to be able to successfully handle the extra weight, CPc experienced 317 
difficulties to walk with the increased demand. TDc walked with larger ranges of joint 318 
motion, and higher moments and powers in response to the added weight (Table 2, Figure 2). 319 
In fact, it appeared that TDc even overcompensated for the extra weight as their resulting gait 320 
was faster and more dynamic (reflected in increased kinetics). In contrast, CPc walked slower, 321 
with smaller step lengths and ranges of joint motion, and decreased moments and powers. 322 
Furthermore, while in TDc the EMG amplitude of the gastrocnemius muscle increased as a 323 
result of the added weight, in CPc the EMG amplitude slightly decreased (Figure 3). To 324 
increase its force output, a muscle can apply two strategies (or a combination of both). Either 325 
more motor units are recruited, or the activity of already recruited motor units is 326 
synchronized. The first strategy will increase both the EMG frequency and amplitude, while 327 
the latter decreases the EMG frequency whilst increasing the amplitude (Lauer et al., 2008). 328 
As the EMG amplitude slightly decreased in CPc, it appears that in CP the muscles failed to 329 
successfully increase their force output during weighted walking. This finding is supported by 330 
the conclusions in the study of Dallmeijer et al. (2011) who found that the lower limb muscles 331 
of CPc are characterized by a small muscle reserve during walking (Dallmeijer et al., 2011). 332 
When the CP group was further subdivided into children with adequate and moderate lower 333 
limb muscle strength, no significant differences in 3DGA parameters were found due to the 334 
added weight in the two subgroups. As such, it appears that the difference in muscle strength 335 
between the two CP strength subgroups did not lead to a significantly different response to the 336 
added weight. Nevertheless, both CP subgroups presented with difficulties to walk as a result 337 
of an increase in weight. 338 
Previous research already provided an indication that weight could have a negative impact on 339 
the gait pattern in CPc. Specifically, the sudden increase in body weight during the pubertal 340 
growth spurt has been previously related to a more rapid development of the crouch gait 341 
pattern in children with diplegic CP (Gage, 2004). This rapid development was suggested to 342 
be related to increased body mass with an unfavorable mass-to-strength ratio; i.e. weak 343 
muscles can no longer support the toe walking pattern due to the sudden increase in weight 344 
(Kedem and Scher, 2016). 345 
The finding that an increase in body weight has significant negative consequences on several 346 
gait parameters in CPc that are frequently used in clinical gait analysis (and the overall gait 347 
pattern) is of high clinical importance. Given the fact that interventions in CPc are often 348 
evaluated via pre- and post 3D-gait analyses, clinical gait analysists should take into account 349 
the increase in weight of the patient, definitely if the assessments take place during or close to 350 
the growth spurt. If not, unfavorable (or less favorable than expected) gait outcomes could be 351 
related to the treatment rather than to the increase in body weight.  352 
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These findings underscore the importance of initiatives such as that of the European Union 353 
and the World Health Organization to attempt to cease the rise in overweight and obesity in 354 
children (European Union, 2014; World Health Organization, 2016a). These initiatives are of 355 
vital importance as they can halt the related health problems associated to overweight, but 356 
also stop the negative influence of overweight on the gait pattern in CPc. 357 
 358 
When interpreting the results of the current study, one should consider some possible 359 
limitations. 360 
It could be argued that similar changes in spatiotemporal parameters of gait have been 361 
previously reported as specific markers of balance problems (Liao et al., 1997). However, the 362 
weighted walking task of the current study was specifically designed to increase the body 363 
weight without challenging the equilibrium by adding the weight evenly around the waist and 364 
close to the centre of gravity. Nevertheless, it cannot be ruled out that there was no effect on 365 
balance. Further research could focus on further elucidating the individual role of balance on 366 
(spatiotemporal) gait parameters during weighted walking. 367 
The decrease in EMG amplitude in CPc could also be partly related to muscle fatigue. It has 368 
been described in healthy adults that muscle fatigue influences the EMG signal and e.g. reduces 369 
its frequency (Rogers and MacIsaac, 2011). Fatigue could have played a part in the setup of the 370 
current study, as the muscle endurance during submaximal tasks in CPc is reduced compared 371 
to TDc (Eken et al., 2014). Hence, the combination of the different walking trials with and 372 
without weights, and the reduced capacity of CPc to endure activities could have induced 373 
muscle fatigue. Combined with the fact that CPc have been shown to have a small muscle 374 
reserve during walking (Dallmeijer et al., 2011), this means that the EMG amplitude could not 375 
be increased in CPc. Further research examining the mean EMG frequencies and amplitudes of 376 
lower limb muscles during gait for several consecutive steps of a large group of CP children 377 
might further elucidate this problem. 378 
In the current study, the participants’ response was investigated when the weight of the body 379 
was experimentally/artificially increased. This allowed us to investigate fundamental changes 380 
in the gait pattern in TDc and CPc as a response to a sudden increase in body weight. It could, 381 
however, be argued that an increase in body weight in daily life (as happens with overweight 382 
and obesity) occurs over a long period of time in which the gait pattern can slowly adapt. Even 383 
though the participants in the current study received some practice trials with the weights (until 384 
they indicated to feel comfortable with the weights), it is possible that a longer period of 385 
adaption could have an impact on the gait pattern changes. Nevertheless, results from previous 386 
studies in people with overweight and obesity support our findings (e.g. increase in EMG 387 
activations, and knee power generation in TDc). Furthermore, our experimental setup could be 388 
specifically interesting in the case of a more rapid increase in body weight which occurs during 389 
the growth spurt (Day et al., 2007). In this case, however, one should consider that the current 390 
setup does not take into account the combination of the lengthening of the body combined with 391 
the increase in body weight. Hence, the weight increase during the growth spurt is spread over 392 
the body rather than focused on the trunk. 393 
 394 
In conclusion, the results of the current paper indicate that a multitude of gait parameters 395 
(including spatiotemporal measures, kinematics, kinetics, and EMG) are significantly 396 
influenced by adding 10% body weight during walking in TDc and CPc. Furthermore, many of 397 
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these gait parameters differed significantly between TDc and CPc in response to the added 398 
weight. Given the rapid increase in body weight during the growth spurt in CPc, specialists in 399 
clinical gait analysis should take into account the negative effect of the increased body weight 400 
during pre-post measurements to avoid misinterpretation of the treatment results. Overweight 401 
and obesity in CPc should be counteracted or prevented as the increased weight has a 402 
detrimental effect on their gait pattern (and other health issues). 403 
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Figure legends 531 
Figure 1. Schematic overview of the set-up of the study. The difference scores (walking with 532 
added weights vs. weight-free walking) of TD children, all CP children from the CP study 533 
group, CP children with adequate strength, and CP children with moderate strength are 534 
compared in the current study. In the weighted walking task, 10% of the body weight was 535 
added evenly around the waist by means of a black belt. The belt was positioned close to the 536 
location of S2 to avoid challenging the equilibrium and ensuring full visibility of the markers 537 
of the lower limb Plug-in-Gait marker set. 538 
 539 
Figure 2. Mean (+ SE) 3D gait analysis parameters that significantly differed in response to 540 
walking with added weight between typically developing children (TD) and children with 541 
cerebral palsy (CP) and/or between TD, CP children with adequate strength (aCP) and CP 542 
children with moderate strength (mCP). Black bars represent the weight-free trials, white bars 543 
represent the weighted walking trials. See Table 2 and 3 for specific significance values. m= 544 
meter, % GC= percentage of gait cycle, m/s= meter per second, Gas= gastrocnemius muscle, 545 
ampl= amplitude. * p≤0.05, ** p≤0.01, *** p≤0.001 546 
 547 
Figure 3. The EMG amplitude difference scores [mean (+ SE)] of the gastrocnemius muscle 548 
for the typically developing children (TD) and the children with cerebral palsy (CP) in 549 
response to walking with added weights. Comparisons are made to the full CP study group 550 
and separately to the two muscle strength CP sub-groups: aCP= adequate lower limb strength, 551 
mCP= moderate lower limb strength. Difference scores are expressed as percentage 552 
increase/decrease. * p≤0.05.553 In revi
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Tables 554 
Table 1. Participant characteristics 555 
 CP group  TD group 
 Adequate muscle 
strength group 
(n=17) 
Moderate muscle 
strength group 
(n=13) 
 Typical: typical muscle 
strength group 
(n=15) 
Average age (SD) 9y 6m (±1y 3m) 6y 5m (±2y 3m)  8y 6m (±1y 3m) 
Average weight (SD) 31.8kg (±10.7kg) 24.3kg (±9.3kg)  29.8kg (±7.6kg) 
Median (IQR) range of motion 
(degrees) 
    
Hip extension 0° (0° – 0°) 0° (-5° – 0°)  Nr 
Knee extension 0° (0° – 0°) 0° (0° – 5°)  Nr 
Ankle dorsiflexion 0° (0° – 10°) 5° (0° – 10°)  Nr 
Selectivity (range 0-2)     
Knee flexors 2 (2 – 2) 1.5 (1.5 – 2)  Nr 
Knee extensors 2 (2 – 2) 2 (1.5 – 2)  Nr 
Ankle plantarflexors 1.5 (1.25 – 2) 1.5 (1 – 1.5)  Nr 
Diagnosis CP CP  TD 
Unilateral 9 3  Na 
Bilateral 8 10  Na 
GMFCS     
I 13 4  Na 
II 4 9  Na 
SD= standard deviation; y= years; m= months; IQR= interquartile range; range of motion= maximal joint angle achieved passively; Nr= normal; CP= cerebral palsy; TD= 556 
typically developing; Na= not applicable; GMFCS= Gross Motor Functional Classification Score. 557 
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Table 2. Overview of the spatiotemporal, kinematic and kinetic 3DGA parameters that responded significantly different to walking with added 558 
weight between typically developing (TD) children and children from the full CP group, CP children with adequate strength (aCP), and CP children 559 
with moderate strength (mCP). The values of these parameters for both baseline (weight-free) walking trials and weighted walking trials are 560 
presented. 561 
  TD  CP  aCP  mCP  
3DGA parameter  
Weight-free 
(±SE) 
Weighted 
(±SE) 
 Weight-free 
(±SE) 
Weighted 
(±SE) 
 
Weight-free 
(±SE) 
Weighted 
(±SE) 
 
Weight-free 
(±SE) 
Weighted 
(±SE) 
 
Step length (m)  0.54 (0.02) 0.57 (0.03)  0.46 (0.02) 0.44 (0.02)  0.49 (0.02) 0.48 (0.02)  0.42 (0.02) 0.39 (0.03)  
Walking velocity (m/s)  1.17 (0.03) 1.28 (0.06)  1.03 (0.04) 0.94 (0.04)  1.09 (0.04) 1.02 (0.05)  0.94 (0.06) 0.83 (0.06)  
Stride length (m)  1.07 (0.03) 1.14 (0.05)  0.95 (0.03) 0.89 (0.04)  1.03 (0.04) 0.96 (0.04)  0.84 (0.04) 0.78 (0.05)  
Duration of double 
support (s) 
 0.18 (0.01) 0.16 (0.01) 
 
0.18 (0.01) 0.22 (0.01)  0.18 (0.02) 0.21 (0.01)  0.17 (0.02) 0.24 (0.03)  
Timing of foot-off (%GC)  59.4 (0.5) 58.9 (0.4)  57.9 (0.7) 60.6 (0.7)  58.48 (0.95) 60.35 (0.89)  57.18 (1.07) 60.96 (1.09)  
Pelvic rom, cor (°)  7.3 (0.4) 8.0 (0.4)  11.6 (0.7) 9.2 (0.6)  11.57 (1.05) 9.29 (0.89)  11.52 (0.92) 8.97 (0.88)  
Max hip fl swing (°)  35.3 (1.1) 39.1 (1.2)  44.6 (1.6) 44.9 (1.6)  44.15 (2.37) 45.41 (2.24)  45.16 (1.90) 44.28 (2.16)  
Hip rom, sag (°)  45.3 (1.1) 50.1 (1.3)  46.9 (1.5) 48.1 (1.8)  47.22 (2.50) 47.26 (2.58)  46.54 (1.37) 49.17 (2.52)  
Hip rom, cor (°)  12.6 (0.7) 14.1 (0.6)  14.4 (0.7) 13.6 (0.9)  14.68 (1.12) 13.22 (1.15)  13.98 (0.83) 14.09 (1.34)  
Hip rom, trans (°)  21.3 (1.0) 25.6 (1.6)  21.7 (1.1) 20.1 (1.0)  23.47 (1.10) 21.63 (0.85)  19.40 (1.91) 18.03 (1.99)  
Max hip fl vel in swing 
(°/s) 
 220.5 (6.6) 251.5 (10.0) 
 
223.6 (9.1) 229.8 (11.2)  226.1 (14.2) 229.3 (16.8)  220.5 (10.5) 230.5 (14.6)  
Max plfl vel at toe-off 
(°/s) 
 161.9 (12.8) 200.9 (10.2) 
 
127.0 (7.8) 121.2 (9.8)  128.4 (10.4) 116.0 (10.5)  125.1 (12.2) 128.1 (18.3)  
Max hip ext moment in 
stance (Nm) 
 0.50 (0.08) 0.98 (0.07) 
 
0.99 (0.07) 0.80 (0.07)  1.11 (0.09) 0.90 (0.09)  0.79 (0.09) 0.62 (0.10)  
Max hip power gen in 
stance (W) 
 0.49 (0.09) 0.76 (0.07) 
 
1.36 (0.16) 1.07 (0.14)  1.42 (0.22) 1.18 (0.20)  1.25 (0.21) 0.88 (0.15)  
Max hip power abs in 
stance (W) 
 -0.69 (0.05) -0.97 (0.08) 
 
-0.97 (0.09) -0.94 (0.09)  -0.99 (0.11) -1.01 (0.12)  -0.92 (0.16) -0.82 (0.14)  
Max hip power gen at toe-
off (W) 
 1.30 (0.09) 1.65 (0.16) 
 
1.15 (0.11) 1.08 (0.14)  1.32 (0.14) 1.33 (0.19)  0.85 (0.16) 0.63 (0.10)  
Max knee power gen in 
stance (W) 
 0.54 (0.06) 0.99 (0.13) 
 
0.89 (0.14) 0.89 (0.16)  1.00 (0.20) 1.01 (0.23)  0.69 (0.13) 0.67 (0.11)  
Max ankle power abs at 
loading response (W) 
 -0.63 (0.08) -0.73 (0.08) 
 
-0.96 (0.09) -0.82 (0.08)  -0.95 (0.12) -0.83 (0.10)  -0.97 (0.15) -0.81 (0.14)  
TD= typically developing; CP= cerebral palsy; 3DGA= 3D gait analysis; SE= standard error; rom= range of motion; cor= coronal plane; sag= sagittal plane; trans= transversal 562 
plane; max= maximal; fl= flexion; plfl= plantarflexion; ext= extension; vel= velocity; gen= generation; abs= absorption 563 
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Table 3. Statistically significant 3DGA parameters and their level of significance per statistical comparison. Comparisons were based on the difference 564 
scores between baseline walking and walking with added weights (for the data, see Table 2). 565 
  Mann-Whitney U values, P-values and Effect Sizes of comparisons based on 
difference scores (between baseline walking and weighted walking) 
 
3DGA parameter  TD vs. CP TD vs. aCP TD vs. mCP aCP vs. mCP  
Step length (m)  89 (.03) / -0.45 ns ns ns  
Walking velocity (m/s)  81 (.02) / -0.49 ns ns ns  
Stride length (m)  86 (.02) / -0.47 ns ns ns  
Duration of double support (s)  74 (.02) / -0.49 ns ns ns  
Timing of foot-off (% GC)  56 (<.01) / -0.59 40 (<.01) / -0.57 16 (<.01) / -0.68 ns  
Pelvic rom, cor (°)  55 (<.01) / -0.61 23 (<.001) / -0.70 32 (<.01) / -0.57 ns  
Max hip fl swing (°)  64 (<.01) / -0.58 53 (<.01) / -0.50 11 (.001) / -0.75 ns  
Hip rom, sag (°)  113 (.03) / -0.40 ns ns ns  
Hip rom, cor (°)  108 (.03) / -0.42 ns ns ns  
Hip rom, trans (°)  92 (.02) / -0.48 ns ns ns  
Max hip fl vel in swing (°/s)  108 (.03) / -0.42 ns ns ns  
Max plfl vel at toe-off (°/s)  91 (.02) / -0.48 ns ns ns  
Max hip ext moment in stance (Nm)  28 (<.001) / -0.70 15 (<.001) / -0.75 13 (<.01) / -0.66 ns  
Max hip power gen in stance (W)  82 (.02) / -0.47 ns ns ns  
Max hip power abs in stance (W)  89 (.03) / -0.44 ns ns ns  
Max hip power gen at toe-off (W)  88 (.03) / -0.44 ns ns ns  
Max knee power gen in stance (W)  89 (.03) / -0.40 ns ns ns  
Max ankle power abs at loading 
response (W) 
 
96 (.04) / -0.42 ns ns ns  
Mean EMG ampl gastroc 
increase/decrease (%) 
 
108 (.03) / -0.42 ns ns ns  
Data is presented as follows; U-value (p-value) / Effect size. 3DGA= 3D gait analysis; TD= typically developing; CP= cerebral palsy study group; aCP= adequate strength CP group; 566 
mCP= moderate strength CP group; ns= not significant; na= not applicable; rom= range of motion; cor= coronal plane; sag= sagittal plane; trans= transversal plane; max= maximal; fl= 567 
flexion; plfl= plantarflexion; ext= extension; vel= velocity; gen= generation; abs= absorption; ampl= amplitude; gastroc= gastrocnemius muscle 568 
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